Neurological disorders, including Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis, pose significant challenges due to their complex pathophysiology ...

Pharmaceutical industry experts at Gitex Asia 2025 discuss how AI is revolutionising drug discovery, from accelerating ...

Ashok Krish told PTI in an interview true high-value implementations are happening in companies that see AI not as an IT ...

Eric Schmidt’s AI predictions reveal a future of innovation, risks, and ethical dilemmas. Are we ready for the rise of ...

DHA R&D-MRDC researchers are applying the latest regulatory guidance related to AI to better carry out their mission to develop life-saving medicines.

Ex-Google CEO Eric Schmidt warns AI could surpass human control by 2026. Discover the risks and opportunities of artificial ...

The firms will explore molecular mechanisms and patient responses in cancer to inform development of new therapies.

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire therapeutic landscape and the whole drug discovery pipeline.

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to ...

View software available in the Integrated Systems Biology and AI — Tailored Pharmacology and Precision Medicine Lab led by Hu ...